semaglutide for the treatment of obesity Study reveals oral 50 mg as promising in adults: Lancet report Recommend semaglutide and tirzepatide as

Electrolyte balance: Its important to get adequate potassium and magnesium from whole foods to support normal rhythm

From 1st week: Reduced pain (noticeable within 3-7 days) Decreased inflammation Improved range of motion Better sleep (reduced pain at night) By week 2-3: Significant pain reduction Return to light activity possible Improved tissue mobility Reduced morning stiffness Week 4-6: Major healing progress Return to normal activities for minor injuries Continued improvement for moderate injuries Tissue strength improving Week 6-8: Near complete recovery for minor injuries Significant improvement for moderate injuries Reduced risk of re-injury Can increase activity level safely Realistic expectations: BPC-157 might cut healing time by 30-50%

Research published this week has found that GLP-1 drugs are associated with a lower risk of dementia in people with type 2 diabetes

strict eligibility: patients must have experienced a cardiovascular event such as a heart attack, stroke, or symptomatic peripheral arterial disease

Learn more about who can take GLP-1s